Published on
11:00 GMT
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet ...
Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
:max_bytes(150000):strip_icc()/kelly-clarkson-lenny-kravitz-mariah-carey-020625-14dc251bcb464632be0c7c66f6105f5d.jpg)
